Travere Therapeutics Inc
NASDAQ:TVTX

Watchlist Manager
Travere Therapeutics Inc Logo
Travere Therapeutics Inc
NASDAQ:TVTX
Watchlist
Price: 18.47 USD -0.48% Market Closed
Market Cap: 1.4B USD
Have any thoughts about
Travere Therapeutics Inc?
Write Note

Travere Therapeutics Inc
Total Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Travere Therapeutics Inc
Total Assets Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Assets CAGR 3Y CAGR 5Y CAGR 10Y
Travere Therapeutics Inc
NASDAQ:TVTX
Total Assets
$504.4m
CAGR 3-Years
-13%
CAGR 5-Years
-4%
CAGR 10-Years
13%
Abbvie Inc
NYSE:ABBV
Total Assets
$143.4B
CAGR 3-Years
-1%
CAGR 5-Years
19%
CAGR 10-Years
18%
Gilead Sciences Inc
NASDAQ:GILD
Total Assets
$54.5B
CAGR 3-Years
-7%
CAGR 5-Years
-2%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Total Assets
$90.9B
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Assets
$22.2B
CAGR 3-Years
21%
CAGR 5-Years
24%
CAGR 10-Years
25%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Assets
$37.4B
CAGR 3-Years
17%
CAGR 5-Years
22%
CAGR 10-Years
26%

See Also

What is Travere Therapeutics Inc's Total Assets?
Total Assets
504.4m USD

Based on the financial report for Sep 30, 2024, Travere Therapeutics Inc's Total Assets amounts to 504.4m USD.

What is Travere Therapeutics Inc's Total Assets growth rate?
Total Assets CAGR 10Y
13%

Over the last year, the Total Assets growth was -39%. The average annual Total Assets growth rates for Travere Therapeutics Inc have been -13% over the past three years , -4% over the past five years , and 13% over the past ten years .

Back to Top